Licensing and investment opportunities emerging from Japan




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Licensing and investment opportunities emerging from Japan
Released on: November 18, 2009. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    The Japan Biotech Forum held in London in September 2009 brought together Japanese biotech companies to discuss strategies adopted to create value and mitigate risk.
  • Summary
  • Company
The Japan Biotech Forum held in London in September 2009 brought together Japanese biotech companies to discuss strategies adopted to create value and mitigate risk.

REGISTER for the 2010 Japan Biotechnology Forum, to be held at the Royal Society in London in September.
TransB
transB is a consulting firm that provides business intelligence services which focus on the Japanese biotech and pharmaceutical sectors. Our vision is to provide clients with the best information and analysis to enable them to make informed decisions that will lead to successful cross-border transactions. The role of transB is to act as a powerful catalyst that bridges the information of advanced science/technologies and business needs that exist between Japanese biotech communities on the global stage.